Aimns-To generate new monoclonal antibodies directed against melanoma associated antigens using a new melanoma cell line, KAL. Methods-The melanoma cell line was established in culture from a lymph node metastasis of malignant melanoma. Normal Balb/c mice were immunised with KAL cells. Splenocytes were used for fusion experiments using standard techniques. Hybridoma supernatants were tested for antibody binding activity using an indirect inumunoperoxidase method on frozen sections from KAL tumour cells xenografted onto nude mice and human tonsils. KBA.62 was selected because of its reactivity with melanocytic proliferations on both frozen and paraffin wax sections. Results-On immunoblotting, KBA.62 reacted with three bands of 140, 135 and 128 kD and two weak bands of 88 and 73 kD. In normal human tissues basal melanocytes in the epidermis did not react with this antibody and only occasional labelling of endothelial cells was noted. Of the human tumours, KBA.62 reacted strongly and uniformly with the majority of benign (21/ 21) and malignant (75/86) melanocytic proliferations. Staining was localised predominantly to the cell membrane with little or no cytoplasmic reactivity. Negative staining was observed in the majority of human non-melanocytic neoplasms, the exceptions being some carcinomas (11/89), particularly the well differentiated squamous cell type. This, however, was not thought to present a diagnostic problem. Conclusions-KBA.62 appears to be potentially useful in ascertaining the immunomorphological diagnosis of malignant melanoma in routinely processed paraffin wax sections. (J Clin Pathol 1995;48:826-831) 
Malignant melanoma may sometimes constitute a diagnostic problem in surgical pathology and may mimic other neoplasms, such as undifferentiated carcinoma, sarcoma or large cell lymphoma. The advent of monoclonal antibodies directed against formalin resistant melanoma associated antigens has provided a useful tool for the diagnosis of malignant melanomas even in their amelanotic form.'-3 A few antimelanoma antibodies, reactive on paraffin wax sections, are now available. The usefulness of anti-SlO0 protein and NKI/C-3 in the diagnosis of melanocytic proliferations is limited as these antibodies recognise antigens not restricted to melanoma. Indeed, these antibodies react with a broad range of benign and malignant neoplasms24"6 and thus must be used in conjunction with other antibodies to allow definitive immunohistochemical diagnosis. 27 As yet, HMB-45 has proved to be the most specific and useful monoclonal antibody in routine histopathology. 8 Here, we report the production of a monoclonal antibody (KBA.62) directed against a melanoma associated antigen which survives fixation and thus can be used on routinely processed paraffin wax sections. Detailed analysis of the reactivity of KBA.62 on normal and malignant human tissues is presented. These findings in melanocytic proliferations were compared with those obtained with HMB-45, which was used as a reference antibody. Several cases were also immunostained with anti-S 100 polyclonal antibody.
Methods

ESTABLISHMENT OF THE KAL CELL LINE AND ITS TRANSPLANTATION INTO NUDE MICE
The melanoma cell line (KAL) was established in culture from a lymph node metastasis of malignant melanoma. A fragment of the fresh tissue was minced with a scalpel blade and incubated in RPMI medium supplemented with 20% fetal calfserum (FCS) and antibiotics at 37°C in a 5% CO2 humidified environment.
After 24 hours, only adherent cells were conserved. After two weeks in culture, cells growing in a monolayer were harvested using trypsin/ EDTA (0 05/0 02%) and used for further subculture. The cell line, KAL, has been now maintained in RPMI/10% FCS for more than two years. The inoculation of 10-20 x 106 'KAL cells subcutaneously into nude mice caused tumour formation in all inoculated mice, within about three weeks. The KAL tumours from heterotransplanted animals were either snap frozen in liquid nitrogen or fixed in DuboscqBrasil (ethanol based Bouin's) fluid and prepared for later screening of hybridoma supernatants.9
A novel anti-melanoma antibody reactive on paraffin wax sections 
For immunoblotting analysis, KAL cells were lysed in lysis buffer containing 1 % Nonidet P-40 (Sigma, St Louis, Missouri, USA) in 50 mM Tris/HCl (pH 8-0), 0-15M NaCl, 0-57mM phenylmethylsulphonyl fluoride, and 0 15 ,M aprotinin at 40C for 30 minutes. After centrifugation, the samples were separated by SDSpolyacrylamide gel electrophoresis (7 5%) according to Laemmli's method'7 and transferred to nitrocellulose membranes according to the method of Towbin et al. 8 Nitrocellulose sheets were incubated with KBA.62 monoclonal antibody and the bound antibody was targeted with rabbit anti-mouse and swine anti-rabbit peroxidase conjugates. The peroxidase activity was revealed using the enhanced chemiluminescence western blotting detection system (Amersham, Little Chalfont, UK).
Results
HYBRIDOMA PRODUCTION AND SELECTION OF
KBA.62
Supematants from six of 924 hybridomas reacted with frozen KAL tumour sections but were negative on human tonsil sections, suggesting that a melanoma associated antigen had been detected. Of these six, the KBA.62 clone (IgG2a subclass) was selected for further detailed analysis because of its reactivity on both frozen and paraffin wax sections. Immunoblotting analysis performed with KBA.62 produced three bands with apparent molecular weights of 140, 135 and 128 kD and two weak bands of 88 and 73 kD (fig 1) . the staining intensity observed with each antibody varied from case to case (figs 2E and 2F). Furthermore (fig 2A) . Epithelioid melanoma usually showed stronger and more consistent staining than the sarcomatous, spindle cell variant.
Overall, the reactivities of KBA.62 and HMB-45 on melanocytic tumours were comparable, with the notable exception of the dermal component of the intradermal type and compound naevi (figs 2C and 2D). In the latter the intradermal cells were consistently labelled with KBA.62 ( fig 2C) and were weakly positive or negative with HMB-45 ( fig 2D) . In addition, (figs 2A and 2B) . However, the precise immunolocalisation of the antigen recognised by KBA.62 on KAL cells, with and without membrane permeabilisation, revealed that the antigen is probably on the inner part of the cell membrane (data not shown). KBA.62 reacts with some epithelial tumours, which is also the case with HMB-45.526 The reactivity of melanocytic neoplasms with anti-S100 is well documented.127 However, anti-S100 antibodies are of limited diagnostic value because of their broad spectrum of reactivity with nonmelanocytic tumours.45 Thus, the latter marker has to be used in conjunction with other tissue specific immunomarkers.
In summary, KBA.62 is a new monoclonal antibody suitable for use on routinely processed paraffin wax sections. This antibody, in association with other antibodies, may prove to be valuable for a definitive immunomorphological diagnosis of malignant melanoma in surgical pathology practice.
